87
Views
4
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Relationship of the expression of circulating hsa-miR-125a-3p and hsa-miR-125b with breast cancer

, , &
Pages 41-43 | Received 29 Mar 2019, Accepted 27 Aug 2019, Published online: 23 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

NW Brown, G Orchard & A Rhodes. (2020) British Journal of Biomedical Science in 2020. What have we learned?. British Journal of Biomedical Science 77:4, pages 159-167.
Read now

Articles from other publishers (3)

Negar Shafagh Shishavan, Soheila Talesh Sasani, Zivar Salehi & Masoumeh Rezaei Azhang. (2022) Downregulation of miR-125a-5p Leads to STAT3 Increased Expression in Breast Cancer Patients. MicroRNA 11:3, pages 263-270.
Crossref
Sixin Zheng, Lingling Hu, Qingwen Song, Yuqiang Shan, Guang Yin, Hanzhang Zhu, Wencheng Kong & Chunhua Zhou. (2021) miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling. Aging 13:24, pages 26137-26147.
Crossref
I‐Ni Chen, Prasanna Kumar Ganta, Shou‐Jie Chung, Yu‐Lun Chang, Heng‐Yi Chang, Shangwu Ding, Hsuan‐Ying Chen, Chien‐Chih Chiu & Kuo‐Hui Wu. (2021) Titanium complexes bearing 2, 6‐bis ( o ‐hydroxyalkyl)pyridine ligands in vitro cytotoxicity against triple‐negative breast‐cancer cells . Journal of the Chinese Chemical Society 68:5, pages 871-877.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.